Medwaala Pharmaceuticals Private Limited, a active private limited company, was established on 02 January 2017 in Delhi North East, Delhi, India. Engaging in diagnostic centers & pathology labs within the healthcare sector, it holds CIN: U33119DL2017PTC310008. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Gurpreet Kaur (Director), Gurmeet Singh (Director). Past directors included Paramjit Singh, Rajeev Ranjan. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at A-19 F/F, Kh.No-30/2 Main Wazirabad Road Brij Puri, Delhi North East, Delhi, 110094.
U33119DL2017PTC310008
310008
02 January 2017
₹1.00 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Medwaala Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gurpreet Kaur | Director | 21 Feb 2020 | Current |
| Gurmeet Singh | Director | 02 Jan 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Sep 2019 | Past |
| Pramod Abcsdd | Director | 21 Feb 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medwaala Pharmaceuticals Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 2.08% increase. The company also saw a substantial improvement in profitability, with a 102.17% increase in profit. The company's net worth moved up by a moderate rise of 0.96%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Medwaala Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Medwaala Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medwaala Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medwaala Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Medwaala Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Medwaala Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
The activity Gurpreet Kaur was appointed as a Director was appointed as a Director on 21 Feb 2020 & has been associated with this company since 5 years 10 months . was completed.
Progress on Gurmeet Singh was appointed as a Director was appointed as a Director on 02 Jan 2017 & has been associated with this company since 8 years 11 months . was documented.
Progress on Medwaala Pharmaceuticals Private Limited was registered on 02 Jan 2017 with Roc Delhi & aged 8 years 11 months as per MCA records. was documented.
The CIN of Medwaala Pharmaceuticals Private Limited is U33119DL2017PTC310008.
Medwaala Pharmaceuticals Private Limited is headquartered at A-19 F/F, Kh.No-30/2 Main Wazirabad Road Brij Puri, Delhi North East, Delhi, 110094.
Medwaala Pharmaceuticals Private Limited was incorporated on 02 January 2017.
The current directors of Medwaala Pharmaceuticals Private Limited are
The primary industry of Medwaala Pharmaceuticals Private Limited is Healthcare.
Medwaala Pharmaceuticals Private Limited is unlisted.
The authorized capital of Medwaala Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Medwaala Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX